Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Botulinum neurotoxin a/b immune globulin (human)
Drug ID BADD_D00289
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID Not Available
MeSH ID Not Available
PubChem ID Not Available
TTD Drug ID Not Available
NDC Product Code Not Available
Synonyms Not Available
Chemical Information
Molecular Formula Not Available
CAS Registry Number Not Available
SMILES Not Available
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.002--
Acute respiratory distress syndrome22.01.03.001--
Agitation19.06.02.001; 17.02.05.012--
Anaemia01.03.02.001--
Apnoea22.02.01.001--
Atelectasis22.01.02.001--
Back pain15.03.04.005--
Blood pressure decreased13.14.03.002--Not Available
Blood pressure increased13.14.03.005--Not Available
Body temperature decreased13.15.01.010--Not Available
Bronchospasm22.03.01.004; 10.01.03.012--
Cardiac arrest02.03.04.001--
Cardiac murmur13.14.01.001--Not Available
Chills08.01.09.001; 15.05.03.016--
Circulatory collapse24.06.02.001--Not Available
Coma17.02.09.001--Not Available
Cough22.02.03.001--
Cyanosis24.03.01.007; 22.02.02.007; 02.01.02.002--
Dehydration14.05.05.001--
Dermatitis bullous23.03.01.002--
Dermatitis contact23.03.04.004; 12.03.01.040; 10.01.01.003--Not Available
Diarrhoea07.02.01.001--
Dysphagia07.01.06.003--
Dyspnoea22.02.01.004; 02.01.03.002--
Erythema multiforme23.03.01.003; 10.01.03.015--
Haemoglobin decreased13.01.05.003--Not Available
Haemolysis01.06.04.002--
Hepatic function abnormal09.01.02.001--Not Available
Hypertension24.08.02.001--
The 1th Page    1 2 3    Next   Last    Total 3 Pages